Cancer
-
Innovative cancer clinical trials unit unveiled
Posted on:
Researchers from the Kolling Institute will help progress the latest cancer treatments following the official opening of an early phase clinical trials unit at Royal North Shore Hospital. The early phase unit of the NORTH STAR Van Norton Poche Cancer Trials Centre is a dedicated facility to meet the needs of patients and their carers,…
Category:
-
2026 Beryl and Jack Jacobs Travel Awards announced
Posted on:
A collection of five early-to-mid career researchers will share close to $40,000 in funding through the Skipper Jacobs Charitable Trust. The Skipper family has generously supported emerging research talent at the Kolling Institute for many years, providing invaluable travel and career opportunities. This year’s group has welcomed the chance to travel internationally, meet with research…
Category:
-
Funds to deliver game-changing approach to cancer screening and treatment
Posted on:
Researchers at the Kolling Institute have been awarded significant funding to embed an innovative technique for cancer diagnosis and treatment into healthcare across New South Wales. Delivered by the Cancer Institute NSW, the $3.75 million Translational Program Grant has been awarded to leading clinician and University of Sydney researcher Professor Anthony Gill to test and…
Category:
-
Introducing BRIDGE: A life- changing gift advancing research and treatment for a rare form of bowel cancer
Posted on:
The University of Sydney and the Kolling Institute have launched a groundbreaking research program to transform treatment for one of the most aggressive forms of bowel cancer. Supported by a $1.3 million philanthropic gift, the BRIDGE program offers new hope for patients with BRAFv600e‑mutated bowel cancer. This mutation, present in around 10 per cent of…
Category:
-
The Kolling welcomes Australia’s leading genomics provider to the institute
Posted on:
Researchers within the Kolling Institute will shortly have the chance to strengthen their genomics capabilities, with AGRF – the Australian Genome Research Facility – establishing a laboratory within the institute. The new lab is part of an exciting partnership between AGRF, the University of Sydney and the Kolling which will see a specialised team and…
-
September 2025 Kolling NEWS
Posted on:
Our latest Kolling Institute newsletter is out detailing the very latest updates from our expert team of researchers, including some promising progress with our bowel cancer investigators. There’s an opportunity to join a clinical trial to minimise the impact of osteoarthritis, a new approach to reduce spinal cord injury related pain and an international award recognising 40…
-
Game-changing blood test to detect bowel cancer
Posted on:
Bowel cancer is the third most common type of cancer in Australia and treating it is both costly and complex. Alarmingly, rates are rising among people under 50, and researchers still don’t know why. It is for these reasons that Professor Mark Molloy is on a mission to prevent the disease in the first place. Based…
Category:
-
Podcast offers insight into the future of healthcare
Posted on:
A fascinating and informative podcast has been launched showcasing groundbreaking research, innovative healthcare, and inspiring stories from across Northern Sydney. Tomorrow’s Medicine Today is an initiative of the Northern Sydney Local Health District and the Kolling Institute, New South Wales’ oldest medical research institute. Co-hosted by the Kolling Institute’s Academic Director Professor James Elliott and leading…
-
Celebrating over 100 years of innovation
Posted on:
The inaugural Eva Kolling Research Day was staged within Royal North Shore Hospital, providing the perfect chance to celebrate the vision and generosity of a true pioneer. Established in 1920, the Kolling Institute is the oldest medical research institute in New South Wales. It has been at the forefront of cutting-edge research for more than…
-
Improving cancer detection in young people with neurofibromatosis type 1
Posted on:
Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first study of whole-body screening for young people with neurofibromatosis type 1. Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support…
Category:
Copyright © 2026 Kolling Institute
All rights reserved